Preparation of mesoporous silica nanocarriers targeting glucose-6-phosphate isomerase inhibition and application in the treatment of rheumatoid arthritis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preparation of mesoporous silica nanocarriers targeting glucose-6-phosphate isomerase inhibition and application in the treatment of rheumatoid arthritis
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2023-01-08
DOI
10.1093/cei/uxac116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mesoporous silica nanoparticles combined with AKR1C3 siRNA inhibited the growth of castration-resistant prostate cancer by suppressing androgen synthesis in vitro and in vivo
- (2021) Junyu Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Rheumatoid Arthritis
- (2021) John J. Cush MEDICAL CLINICS OF NORTH AMERICA
- The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application
- (2021) Jun Wu Journal of Personalized Medicine
- Mesoporous silica nanoparticles for pulmonary drug delivery
- (2021) Alba García-Fernández et al. ADVANCED DRUG DELIVERY REVIEWS
- The regulation of macrophage polarization by hypoxia-PADI4 coordination in Rheumatoid arthritis
- (2021) Yu Cheng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy
- (2020) Yazhe Wang et al. ACS Applied Materials & Interfaces
- Glucose-6-phosphate isomerase is associated with disease activity and declines in response to infliximab treatment in rheumatoid arthritis
- (2020) Jing Xu et al. CHINESE MEDICAL JOURNAL
- RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
- (2020) Ai-Ming Yu et al. PHARMACOLOGICAL REVIEWS
- Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer
- (2019) Dnyaneshwar Kalyane et al. Materials Science & Engineering C-Materials for Biological Applications
- siRNA therapeutics: a clinical reality
- (2019) Phei Er Saw et al. Science China-Life Sciences
- The contribution of inflammation and bone destruction to pain in arthritis – a study in murine glucose‐6‐phosphate isomerase (G6PI)‐induced arthritis
- (2019) Matthias Ebbinghaus et al. Arthritis & Rheumatology
- Journey of siRNA: Clinical Developments and Targeted Delivery
- (2018) Rahul R. Nikam et al. Nucleic Acid Therapeutics
- Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery
- (2018) Anna Slita et al. Asian Journal of Pharmaceutical Sciences
- Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances
- (2018) Reema Narayan et al. Pharmaceutics
- Pathogenetic insights from the treatment of rheumatoid arthritis
- (2017) Iain B McInnes et al. LANCET
- Future therapeutic targets in rheumatoid arthritis?
- (2017) Tommy Tsang Cheung et al. Seminars in Immunopathology
- Glucose-6-Phosphate Isomerase (G6PI) Mediates Hypoxia-Induced Angiogenesis in Rheumatoid Arthritis
- (2017) Ying Lu et al. Scientific Reports
- Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review
- (2015) Jaleh Varshosaz et al. CURRENT PHARMACEUTICAL DESIGN
- Nanocarriers for cancer-targeted drug delivery
- (2015) Preeti Kumari et al. JOURNAL OF DRUG TARGETING
- Mesoporous silica nanoparticles in drug delivery and biomedical applications
- (2015) Ying Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Glucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis
- (2015) Ming Zong et al. ARTHRITIS RESEARCH & THERAPY
- Diagnostic value of glucose-6-phosphate isomerase in rheumatoid arthritis
- (2010) Lie Ying Fan et al. CLINICA CHIMICA ACTA
- Rheumatoid arthritis
- (2010) David L Scott et al. LANCET
- Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA/1 mice
- (2009) Lisa Bruns et al. ARTHRITIS RESEARCH & THERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started